Combined chemoradiotherapy and programmed cell death‐ligand 1 blockade leads to changes in the circulating T‐cell receptor repertoire of patients with non‐small‐cell lung cancer

Combined chemoradiotherapy (CRT) and programmed cell death‐ligand 1 (PD‐L1) blockade is a new care standard for unresectable stage III non‐small‐cell lung cancer (NSCLC). Although this consolidation therapy has improved the overall survival of patients with NSCLC, the synergistic action mechanisms o...

Descripción completa

Detalles Bibliográficos
Autores principales: Someya, Masanori, Tokita, Serina, Kanaseki, Takayuki, Kitagawa, Mio, Hasegawa, Tomokazu, Tsuchiya, Takaaki, Fukushima, Yuki, Gocho, Toshio, Kozuka, Yoh, Mafune, Shoh, Ikeuchi, Yutaro, Takahashi, Mamoru, Moniwa, Keigo, Matsuo, Kazuhiko, Hasegawa, Tadashi, Torigoe, Toshihiko, Sakata, Koh‐ichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746040/
https://www.ncbi.nlm.nih.gov/pubmed/36069051
http://dx.doi.org/10.1111/cas.15566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746040/
https://www.ncbi.nlm.nih.gov/pubmed/36069051
http://dx.doi.org/10.1111/cas.15566

Ejemplares similares